Selina Mader, PhD student in the lab of Prof. Rooman, VUB; Belgium, presented on this TRanSLIT project at 4th German Pancreatic Cancer Research Meeting – An Else Kröner Symposium by KFO5002 and CCC-N. Her results entitled ‘ROBO1 Drives Gemcitabine Resistance in Pancreatic Cancer’ were presented as a poster and flash talk on June 17 to June 19, 2024.
Targeting ROBOs and SLIT guidance cues
in the immune-suppressive stromal context
of pancreatic cancer


